Home » Topics » Medical technology

Medical technology
RSS

Phytopharm Sees Encouraging Results In Phase I P54 Study

Jan. 10, 2001

MediGene's Genital Warts Drug Enters Phase III Clinical Trials

Jan. 10, 2001

Acorda Plans To Move Programs Along Following $33.7M Round

Jan. 10, 2001

SADS, A Pro-Cell-Suicide Protein, Down-Regulated In Colon Cancer Tissue, Daiichi Scientists Report

Jan. 10, 2001

Atrix Licenses Leuprogel Rights To Sanofi In Up-To-$60M Alliance

Jan. 10, 2001

GenOdyssee Applies For Patents Covering Genetic Variants Method

Jan. 10, 2001

By James Etheridge

Other News To Note

Jan. 10, 2001

SHIP2 Gene Makes Waves As Potential Type II Diabetes Target

Jan. 10, 2001

By Sharon Kingman

Oxford BioMedica Moving To LSE Following TroVax Trial Approval

Jan. 10, 2001

Raven Biotech Brings In $20.6M To Develop Antibody Therapeutics

Jan. 10, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...